Abstract

Compounding with Controlled Substances

Author(s): Whalen Mary Kate

Issue: Jan/Feb 2002 - Compounding for Pain Management and Dental Medicine

Page(s): 8-10

Download in electronic PDF format for $75

Abstract

The author, an attorney, provides an overview of the Controlled Substances Act and US Drug Enforcement Administration regulations regarding compounding and highlights recent issues regarding the use of controlled substances in formulations. She concludes that compounding pharmacists who compound controlled substances within the parameters for authorized compounding established by their state boards of pharmacy and US Food and Drug Administration guidelines should not have problems with their local Drug Enforcement Administration field office. However, if problems do arise, enforcement actions vary with each field office.

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
Jan/Feb 2002 Pg. 8-10	Compounding with Controlled Substances Author(s): Whalen Mary Kate
Nov/Dec 2012 Pg. 446-450	The Drug Enforcement Agency's Position on "Constructive Transfer" Under the Controlled Substances Act Author(s): Pore R David
Sep/Oct 2021 Pg. 358-362	Determining Whether a Substance is Legal to Compound with Under Section 503A of the FDCA Author(s): Cabaleiro Joe
Nov/Dec 2019 Pg. 511-518	Evaluation of Containment Ventilated Enclosure Performance in Absence of Negative Pressure Containment Secondary Engineering Control Author(s): Hutson Chad, Day A J
May/Jun 2004 Pg. 181-185	Compounding in the Pharmacy Curriculum: Beyond the Basics Author(s): Hinkle Amanda R, Newton Gail D
Jul/Aug 2010 Pg. 310-314	Unique Challenges in Compounding: Managing Severe Musculoskeletal Pain in a Recovered Substance Abuser Author(s): Christiansen Joel, White Lyndell
Jul/Aug 2015 Pg. 311-313	Basics of Compounding: The "Negative" List Author(s): Allen Loyd V
Nov/Dec 2016 Pg. 477-479	The "Lists": What Do They Mean? Author(s): Voliva John
Nov/Dec 2016 Pg. 457-458	U.S. Food and Drug Administration List of Drugs NOT to be Used in Compounded Medications for Humans (The Negative List) Author(s):
Sep/Oct 2022 Pg. 411-418	Sterile Basics of Compounding: Contamination Control Strategies, Part 1 Author(s): Summers Amy
Jul/Aug 2015 Pg. 303-305	U.S. Food and Drug Administration Proposed Guidance Document: Compounding Animal Drugs from Bulk Substances Author(s): Miller David G
Mar/Apr 2006 Pg. 128-133	Controlled Environment Testing Association Applications Guide for the Use of Barrier Isolators in Compounding Sterile Preparations in Healthcare Facilities, Part 1 Author(s): Wagner James T
May/Jun 2006 Pg. 208-211	Controlled Environment Testing Association Applications Guide for the Use of Barrier Isolators in Compounding Sterile Preparations in Healthcare Facilities, Part 2 Author(s): Wagner James T
Nov/Dec 2003 Pg. 477-480	Quality-Control Analytical Methods: Specific-Gravity Determinations of Liquids and Semisolids Author(s): Allen Loyd V Jr
Jan/Feb 2005 Pg. 44-46	The US FDA List of Drugs Not to Be Used in Compounded Medications for Humans (the "Negative List") Author(s): Allen Loyd V Jr, Ashworth Lisa D
May/Jun 2021 Pg. 211-216	Quality Control: Testing for "Micromonsters": Viable Air and Surface Sampling in Aseptic Compounding Author(s): Mulder Kyle
Jul/Aug 2004 Pg. 269-274	Current Topical Treatments in Wound Healing - Part 1 Author(s): Helmke Christopher D
Sep/Oct 2003 Pg. 401-416	An Ounce of Prevention: Controlling Hazards in Extemporaneous Compounding Practices Author(s): Kastango Eric S, Trissel Lawrence A, Bradshaw Brian D
Jul/Aug 2006 Pg. 281-284	Quality Control Analytical Methods: A Guide to Quality Control Testing for the Compounding Pharmacist Author(s): Zolner William J
Sep/Oct 2009 Pg. 412-418	Quality-Control Analytical Methods: Designing a Quality-Control Potency Testing Program for a Compounding Pharmacy Author(s): Zolner William J